|
J Biol Chem, Vol. 273, Issue 26, 16595-16600, June 26, 1998
Dual Regulation of Stromelysin-3 by Fibroblast Growth Factor-2 in
Murine Osteoblasts
Anne M.
Delany and
Ernesto
Canalis
From the Departments of Research and Medicine, Saint Francis
Hospital and Medical Center, Hartford, Connecticut 06105 and the
University of Connecticut School of Medicine, Farmington,
Connecticut 06030
Osteoblasts express stromelysin-3, a matrix
metalloproteinase associated with normal remodeling processes and
with stromal fibroblasts surrounding many invasive carcinomas.
Fibroblast growth factors (FGFs) play an important role in skeletal
development, fracture repair, and osteoblast function. The osteoblastic
cell line MC3T3 was used to study the regulation of stromelysin-3 by FGF-2. Acutely, FGF-2 decreased stromelysin-3 mRNA levels, whereas prolonged treatment caused an induction of stromelysin-3 mRNA. RNA
stability studies and nuclear run-off assays indicated that acute
treatment with FGF-2 decreased stromelysin-3 mRNA stability but did
not alter gene transcription. However, the induction of stromelysin-3
after prolonged treatment with FGF-2 resulted from increased gene
transcription, with no effect on RNA stability. The stimulatory effect
was protein synthesis-dependent, whereas the inhibitory
effect was not. This study demonstrates dual regulation of
stromelysin-3 by FGF-2: acute destabilization of stromelysin-3 mRNA, followed by induction of gene transcription. This complex regulation may be important in the function of stromelysin-3 in bone
and in remodeling processes, such as wound and fracture repair.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y.-H. Yang, H. Deng, W.-M. Li, Q.-Y. Zhang, X.-T. Hu, B. Xiao, H.-H. Zhu, P.-L. Geng, and Y.-Y. Lu
Identification of Matrix Metalloproteinase 11 as a Predictive Tumor Marker in Serum Based on Gene Expression Profiling
Clin. Cancer Res.,
January 1, 2008;
14(1):
74 - 81.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Ornitz and P. J. Marie
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
Genes & Dev.,
June 15, 2002;
16(12):
1446 - 1465.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Beck Jr., B. Zerler, and E. Moran
Gene Array Analysis of Osteoblast Differentiation
Cell Growth Differ.,
February 1, 2001;
12(2):
61 - 83.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Luo, E. Guerin, M.-G. Ludwig, I. Stoll, P. Basset, and P. Anglard
Transcriptional Induction of Stromelysin-3 in Mesodermal Cells Is Mediated by an Upstream CCAAT/Enhancer-binding Protein Element Associated with a DNase I-hypersensitive Site
J. Biol. Chem.,
December 24, 1999;
274(52):
37177 - 37185.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|